Idorsia earns growth boost in Sfr330m deal

Pharma_drugs_adobe_575x375.jpg
By Sam Kerr
20 May 2020

Investors poured into an accelerated trade in Swiss biopharmaceutical company Idorisia on Tuesday night, causing bookrunners to grow the deal by 1m shares. The success of the deal shows how highly investors value growth in the depressed economic environment of the Covid-19 pandemic.

Barclays and Credit Suisse were bookrunners on the 11m share trade which was grown from 10m shares during bookbuild.

The banks launched the deal, following a wall-crossing exercise, at 5:08pm UK time. Within half an hour a second message was sent to investors saying that the ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial